We assessed the PD-L1 expression by stage and its link to cancer severity, focusing further on its prognostic impact in resected stage I cell lung cancer.<h4>Results</h4>The high expression of PD-L1 increased with disease progression (13.0% in IA to 36.2% in III). Here, CD274 is linked to lung carcinoma.